Expert Interview
Future Trends in Obesity Management: Perceptions of Oral GLP-1s Orforglipron & Danuglipron
Ticker(s): PFE, LLYobesity management providers, PIs, and/or KOLs with strong understanding and familiarity with Orforglipron & Danuglipron
What is your opinion on the potential efficacy and safety of these two therapies (Orforglipron & Danuglipron)?
Added By: pharmaadvisorDo you have an opinion on the potential drug-drug interaction (DDI) profile of the two oral GLP-1s?
Added By: pharmaadvisorGiven the rapidly shifting landscape, what are KOLs' opinions on using these two therapies, and how could they be used in future treatment pathways?
Added By: pharmaadvisorAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
